CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $880,858 | -84.0% | 32,331 | -86.9% | 0.00% | -85.7% |
| Q2 2023 | $5,504,005 | -22.2% | 247,371 | -24.3% | 0.01% | -22.2% |
| Q1 2023 | $7,076,170 | +200.0% | 326,693 | +181.3% | 0.01% | +200.0% |
| Q4 2022 | $2,358,641 | -20.2% | 116,132 | +0.7% | 0.00% | -25.0% |
| Q3 2022 | $2,957,343 | -47.7% | 115,341 | -51.5% | 0.00% | -71.4% |
| Q2 2022 | $5,656,000 | +592.3% | 237,861 | +555.6% | 0.01% | +600.0% |
| Q1 2022 | $817,000 | +10.0% | 36,279 | -3.3% | 0.00% | +100.0% |
| Q4 2021 | $743,000 | -1.6% | 37,536 | -2.2% | 0.00% | -50.0% |
| Q3 2021 | $755,000 | -13.1% | 38,368 | -2.9% | 0.00% | 0.0% |
| Q2 2021 | $869,000 | -29.1% | 39,502 | -23.3% | 0.00% | 0.0% |
| Q1 2021 | $1,225,000 | -11.7% | 51,505 | -2.8% | 0.00% | -33.3% |
| Q4 2020 | $1,387,000 | +43.7% | 53,014 | -4.4% | 0.00% | +50.0% |
| Q3 2020 | $965,000 | +2.7% | 55,426 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $940,000 | +12.3% | 55,876 | -20.7% | 0.00% | 0.0% |
| Q1 2020 | $837,000 | 0.0% | 70,421 | +1.8% | 0.00% | 0.0% |
| Q4 2019 | $837,000 | -4.7% | 69,146 | +11.4% | 0.00% | 0.0% |
| Q3 2019 | $878,000 | +26.5% | 62,087 | -0.3% | 0.00% | +100.0% |
| Q2 2019 | $694,000 | -7.0% | 62,279 | -2.0% | 0.00% | -50.0% |
| Q1 2019 | $746,000 | -14.6% | 63,568 | -2.8% | 0.00% | 0.0% |
| Q4 2018 | $874,000 | -13.2% | 65,400 | -8.9% | 0.00% | 0.0% |
| Q3 2018 | $1,007,000 | -10.8% | 71,801 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,129,000 | -6.1% | 71,801 | -1.8% | 0.00% | -33.3% |
| Q1 2018 | $1,202,000 | -10.7% | 73,083 | -2.0% | 0.00% | 0.0% |
| Q4 2017 | $1,346,000 | +67.6% | 74,549 | +79.2% | 0.00% | +50.0% |
| Q3 2017 | $803,000 | +63.5% | 41,598 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $491,000 | +57.4% | 41,598 | +46.2% | 0.00% | 0.0% |
| Q1 2017 | $312,000 | +50.7% | 28,453 | 0.0% | 0.00% | – |
| Q4 2016 | $207,000 | +11.9% | 28,453 | 0.0% | 0.00% | – |
| Q3 2016 | $185,000 | +19.4% | 28,453 | 0.0% | 0.00% | – |
| Q2 2016 | $155,000 | +16.5% | 28,453 | 0.0% | 0.00% | – |
| Q1 2016 | $133,000 | -6.3% | 28,453 | 0.0% | 0.00% | – |
| Q4 2015 | $142,000 | +32.7% | 28,453 | 0.0% | 0.00% | – |
| Q3 2015 | $107,000 | -37.4% | 28,453 | 0.0% | 0.00% | – |
| Q2 2015 | $171,000 | – | 28,453 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |